TempraMed Enters Exclusive Kuwait Distribution Agreement
The agreement represents approximately US$500,000 in potential minimum purchases over its initial term.
Story updates
07:06:58 AM UTC
SquawkNews
TempraMed signed an exclusive distribution agreement with OGM in Kuwait covering VIVI products, with approximately $500K in potential minimum purchases over an initial 36-month term, subject to registration and commercialization steps.Material DetailsContext by AI AnalystThis extends TempraMed’s in…